Key Highlights

  • Revenue rose to USD 19.97 million from USD 19.27 million.
  • Net income was USD 1.30 million, compared with USD 1.11 million.
  • Basic and Diluted Earnings per Share were USD 0.10, compared with USD 0.09.
  • Gross profit was USD 4.61 million, compared with USD 4.31 million.

CPI Aerostructures (NYSE American:CVU) produces custom assemblies against long-term contracts and customer purchase orders, and its third quarter of 2026 showed modest growth across the income statement. Revenue was USD 19.97 million, compared with USD 19.27 million in the prior-year quarter, and Net Income was USD 1.30 million, compared with USD 1.11 million. Basic and diluted earnings per share were USD 0.10, compared with USD 0.09.

Quarterly Costs and Profit

Cost of sales was USD 15.36 million, compared with USD 14.96 million, and Gross Profit was USD 4.61 million, compared with USD 4.31 million. Selling, general and administrative expenses were USD 2.77 million, compared with USD 2.55 million, and income from operations was USD 1.85 million, compared with USD 1.75 million.

Other income was USD 109 thousand, and interest expense was USD 315 thousand, compared with USD 388 thousand. Income before the provision for income taxes was USD 1.64 million, compared with USD 1.37 million, and the provision was USD 342 thousand, compared with USD 253 thousand. Weighted average shares outstanding were 12,929,271 on a basic basis and 13,091,826 on a diluted basis.

The Nine-Month Turnaround

For the nine months ended September 30, 2026, revenue was USD 54.91 million, compared with USD 49.85 million, and gross profit nearly doubled to USD 12.96 million from USD 6.62 million. Selling, general and administrative expenses were USD 8.09 million, compared with USD 8.04 million.

Income from operations came to USD 4.87 million, compared with a loss of USD 1.42 million, and interest expense fell to USD 920 thousand from USD 1.16 million. Net income was USD 3.22 million, against a net loss of USD 1.54 million, and basic and diluted earnings per share were USD 0.25, against a loss of USD 0.12.

Balance Sheet, Debt and Backlog

Total Assets were USD 77.78 million at September 30, 2026, compared with USD 75.24 million at December 31, 2025, and total liabilities were USD 48.18 million, compared with USD 49.44 million. Total current assets were USD 47.39 million, compared with USD 43.41 million, and contract assets were USD 33.65 million, compared with USD 33.67 million. Inventory was USD 727 thousand, Goodwill was USD 1.78 million, and the deferred tax asset, net, was USD 19.19 million, compared with USD 19.89 million.

The line of Credit was USD 9.17 million, compared with USD 8.37 million, and long-term debt, net of current portion, was USD 9.52 million, compared with USD 9.69 million. The company had 13,229,088 shares of common stock issued and outstanding at September 30, 2026, compared with 13,155,061 at December 31, 2025, and the filing reports share issuances upon settlement of restricted stock.

Per the filing, funded Backlog is the total funded value of those contracts and purchase orders, minus whatever has already flowed into operating revenues, while unfunded backlog is an estimate of orders still to come across the expected life of the programs.